U.S. markets close in 3 hours 9 minutes
  • S&P 500

    3,820.44
    -10.95 (-0.29%)
     
  • Dow 30

    30,848.12
    -119.70 (-0.39%)
     
  • Nasdaq

    11,300.53
    -21.71 (-0.19%)
     
  • Russell 2000

    1,719.69
    -21.64 (-1.24%)
     
  • Crude Oil

    97.04
    -2.46 (-2.47%)
     
  • Gold

    1,735.10
    -28.80 (-1.63%)
     
  • Silver

    19.17
    +0.05 (+0.26%)
     
  • EUR/USD

    1.0179
    -0.0091 (-0.89%)
     
  • 10-Yr Bond

    2.8910
    +0.0820 (+2.92%)
     
  • GBP/USD

    1.1909
    -0.0042 (-0.35%)
     
  • USD/JPY

    135.7270
    -0.1150 (-0.08%)
     
  • BTC-USD

    20,253.02
    +692.26 (+3.54%)
     
  • CMC Crypto 200

    438.50
    +2.97 (+0.68%)
     
  • FTSE 100

    7,107.77
    +82.30 (+1.17%)
     
  • Nikkei 225

    26,107.65
    -315.82 (-1.20%)
     

Collegium to Participate in H.C. Wainwright Global Investment Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc.

STOUGHTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022.

Details of the event are as follows:
Presentation Date and Time: Tuesday, May 24, 2022, at 3:30 pm ET

About Collegium Pharmaceutical, Inc.
Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
Head of Investor Relations
adasalla@collegiumpharma.com